| Novel object recognition test for the investigation of learning and memory in mice LM Lueptow Journal of visualized experiments: JoVE, 55718, 2017 | 1000 | 2017 |
| Biased signaling by endogenous opioid peptides I Gomes, S Sierra, L Lueptow, A Gupta, S Gouty, EB Margolis, BM Cox, ... Proceedings of the National Academy of Sciences 117 (21), 11820-11828, 2020 | 112 | 2020 |
| Kappa opioid receptors drive a tonic aversive component of chronic pain SS Liu, S Pickens, NE Burma, I Ibarra-Lecue, H Yang, L Xue, C Cook, ... Journal of Neuroscience 39 (21), 4162-4178, 2019 | 107 | 2019 |
| The contribution of the descending pain modulatory pathway in opioid tolerance LM Lueptow, AK Fakira, EN Bobeck Frontiers in neuroscience 12, 886, 2018 | 78 | 2018 |
| Cyclic GMP–mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice LM Lueptow, CG Zhan, JM O’Donnell Psychopharmacology 233, 447-456, 2016 | 46 | 2016 |
| The roles of phosphodiesterase 2 in the central nervous and peripheral systems C Zhang, Y Yu, L Ruan, C Wang, J Pan, J Klabnik, L Lueptow, HT Zhang, ... Current pharmaceutical design 21 (3), 274-290, 2015 | 40 | 2015 |
| The role of phosphodiesterase-2 in psychiatric and neurodegenerative disorders C Zhang, LM Lueptow, HT Zhang, JM O’Donnell, Y Xu Phosphodiesterases: CNS Functions and Diseases, 307-347, 2017 | 33 | 2017 |
| Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray AR Wilson-Poe, B Wiese, C Kibaly, L Lueptow, J Garcia, P Anand, ... Pain reports 6 (1), e897, 2021 | 18 | 2021 |
| Targeting the recently deorphanized receptor GPR83 for the treatment of immunological, neuroendocrine and neuropsychiatric disorders LM Lueptow, LA Devi, AK Fakira Progress in molecular biology and translational science 159, 1-25, 2018 | 16 | 2018 |
| The role of the neuropeptide PEN receptor, GPR83, in the reward pathway: Relationship to sex-differences AK Fakira, EG Peck, Y Liu, LM Lueptow, NA Trimbake, MH Han, ... Neuropharmacology 157, 107666, 2019 | 13 | 2019 |
| Kappa opioid signaling at the crossroads of chronic pain and opioid addiction CM Cahill, L Lueptow, H Kim, R Shusharla, A Bishop, CJ Evans The Kappa Opioid Receptor, 315-350, 2021 | 11 | 2021 |
| Insights into the neurobiology of craving in opioid use disorder LM Lueptow, EC Shashkova, MG Miller, CJ Evans, CM Cahill Current anesthesiology reports 10, 378-387, 2020 | 11 | 2020 |
| PEN receptor GPR83 in anxiety-like behaviors: differential regulation in global vs amygdalar knockdown AK Fakira, LM Lueptow, NA Trimbake, LA Devi Frontiers in Neuroscience 15, 675769, 2021 | 10 | 2021 |
| Phosphodiesterases: CNS Functions and Diseases HT Zhang, Y Xu, JM O'Donnell Springer, 2017 | 8 | 2017 |
| Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities S Khoja, J Lambert, M Nitzahn, A Eliav, YC Zhang, M Tamboline, CT Le, ... Molecular Therapy-Methods & Clinical Development 25, 278-296, 2022 | 7 | 2022 |
| Mice heterozygous for a null mutation of CPE show reduced expression of carboxypeptidase e mRNA and enzyme activity but normal physiology, behavior, and levels of neuropeptides LD Fricker, ML Duarte, A Jeltyi, L Lueptow, AK Fakira, AK Tashima, ... Brain research 1789, 147951, 2022 | 3 | 2022 |
| Identification of small molecule ligands targeting GPR83, a G‐protein coupled receptor activated by the abundant neuropeptide PEN LM Lueptow, I Gomes, A Gupta, R Sanchez, L Devi The FASEB Journal 32, 829.9-829.9, 2018 | 1 | 2018 |
| Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests, Volume II. TD Gould Humana Press, 2016 | 1 | 2016 |
| Differential-Reinforcement-of-Low-Rate Behavior in Rodents as a Screen for Antidepressant Efficacy LM Lueptow, JM O’Donnell Mood and Anxiety Related Phenotypes in Mice: Characterization Using …, 2011 | 1 | 2011 |
| Use of an Oversized AAV8 Vector for CPS1 Deficiency Results in Long-Term Survival and Ammonia Control T Diep, W Zhou, RE Reyes, M Nitzahn, IL Day, G Makris, L Lueptow, ... Molecular Therapy Nucleic Acids, 2025 | | 2025 |
